RenovoRx, Inc.
USD0.94
+0.01 (+1.47%)
CEO
Shaun R. Bagai
IPO Date
2021-08-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.93
Prev. Close
$0.93
Day Low
$0.92
Day High
$1.00
52W Low
$0.70
52W High
$1.45
Market Cap
$0.04B
Volume
0.53M
| $3.95 |
| 24 Jun 2026 | RYAN UNA S | director | J-Other | Acquired | 26,838 | $0.93 |
| 24 Jun 2026 | RYAN UNA S | director | J-Other | Acquired | 16,206 | $1.62 |
| 21 May 2026 | VOLL MARK | Chief Financial Officer | P-Purchase | Acquired | 25,000 | $0.79 |
| 7 Apr 2026 | Bagai Shaun | director, officer: Chief Executive Officer | A-Award | Acquired | 946,107 | $0.98 |
| 7 Apr 2026 | VOLL MARK | Chief Financial Officer | A-Award | Acquired | 80,000 | $0.00 |
| 7 Apr 2026 | Gentry Leesa | Chief Clinical Officer | A-Award | Acquired | 128,550 | $0.98 |
| 7 Apr 2026 | Agah Ramtin | director, officer: Chief Medical Officer | A-Award | Acquired | 621,727 | $0.98 |
| 27 Mar 2026 | VOLL MARK | Chief Financial Officer | A-Award | Acquired | 12,380 | $0.00 |